Skip to main content
Livermore
Livermore
ZHEN

True North Advisors, LLC

SEC CIK
0001634556
Latest filing
Jul 22, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by True North Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
15,735
Value
$3.96M
% of portfolio
0.4%
Quarters held
21
Since Q1 2021
Holdings of ABBV by True North Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,735$3.96M0.4%−2,892−15.5%ReducedHolders
Q1 202618,627$4.05M0.5%+16+0.1%AddedHolders
Q4 202518,611$4.25M0.5%+406+2.2%AddedHolders
Q3 202518,205$4.22M0.7%+1,011+5.9%AddedHolders
Q2 202517,194$3.19M0.6%−6,499−27.4%ReducedHolders
Q1 202523,693$4.96M0.9%−2,362−9.1%ReducedHolders
Q4 202426,055$4.63M1.1%+20,553+373.6%AddedHolders
Q3 20245,502$1.09M0.3%−20−0.4%ReducedHolders
Q2 20245,522$947.1K0.3%−1,107−16.7%ReducedHolders
Q1 20246,629$1.21M0.3%+118+1.8%AddedHolders
Q4 20236,511$1.01M0.3%−169−2.5%ReducedHolders
Q3 20236,680$995.7K0.3%−161−2.4%ReducedHolders
Q2 20236,841$921.7K0.3%+2,109+44.6%AddedHolders
Q1 20234,732$754.2K0.2%+426+9.9%AddedHolders
Q4 20224,306$696.0K0.2%+676+18.6%AddedHolders
Q3 20223,630$487.0K0.2%−342−8.6%ReducedHolders
Q2 20223,972$608.0K0.2%+3,972NewHolders
Q1 20220$00.0%−6,445−100.0%Sold outHolders
Q4 20216,445$872.0K0.1%−3,977−38.2%ReducedHolders
Q3 202110,422$1.12M0.2%+2,786+36.5%AddedHolders
Q2 20217,636$860.0K0.2%+431+6.0%AddedHolders
Q1 20217,205$779.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.